SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 34 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $547,000 | +3.4% | 235,967 | +3.6% | 0.00% | – |
Q4 2018 | $529,000 | -84.6% | 227,818 | -1.9% | 0.00% | – |
Q3 2018 | $3,441,000 | +3.6% | 232,226 | +6.2% | 0.00% | – |
Q2 2018 | $3,322,000 | -14.6% | 218,598 | +5.6% | 0.00% | – |
Q1 2018 | $3,888,000 | +362.9% | 207,026 | +347.5% | 0.00% | – |
Q4 2017 | $840,000 | +43.3% | 46,259 | +75.8% | 0.00% | – |
Q3 2017 | $586,000 | – | 26,307 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 758,610 | $11,523,000 | 8.50% |
Wildcat Capital Management, LLC | 295,613 | $4,490,000 | 3.44% |
Cohen Capital Management, Inc. | 115,420 | $1,753,000 | 0.41% |
CLOUGH CAPITAL PARTNERS L P | 292,695 | $4,446,000 | 0.40% |
PFM Health Sciences, LP | 1,551,293 | $23,564,000 | 0.37% |
Asymmetry Capital Management, L.P. | 24,516 | $372,000 | 0.37% |
Partner Investment Management, L.P. | 17,343 | $263,000 | 0.21% |
IFP Advisors, Inc | 180,552 | $2,743,000 | 0.12% |
TIVERTON ASSET MANAGEMENT LLC | 78,031 | $1,185,000 | 0.06% |
Artal Group S.A. | 99,000 | $1,504,000 | 0.03% |